Farther Finance Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.2M Buy
119,959
+12,189
+11% +$2.62M 0.24% 80
2026
Q1
$23.2M Buy
107,770
+17,311
+19% +$3.84M 0.22% 91
2025
Q4
$20.7M Buy
90,459
+42,801
+90% +$9.75M 0.22% 85
2025
Q3
$11M Buy
47,658
+8,558
+22% +$1.74M 0.17% 108
2025
Q2
$7.26M Buy
39,100
+4,908
+14% +$912K 0.15% 130
2025
Q1
$7.05M Buy
34,192
+11,387
+50% +$2.21M 0.18% 114
2024
Q4
$4.05M Sell
22,805
-458
-2% -$84.2K 0.15% 128
2024
Q3
$4.59M Buy
23,263
+3,542
+18% +$661K 0.17% 104
2024
Q2
$3.36M Buy
19,721
+1,409
+8% +$233K 0.16% 108
2024
Q1
$3.31M Buy
18,312
+1,461
+9% +$252K 0.2% 94
2023
Q4
$2.61M Buy
16,851
+11,017
+189% +$1.61M 0.19% 102
2023
Q3
$870K Buy
5,834
+941
+19% +$138K 0.14% 132
2023
Q2
$659K Buy
4,893
+905
+23% +$133K 0.14% 131
2023
Q1
$636K Buy
3,988
+1,239
+45% +$189K 0.19% 103
2022
Q4
$444K Buy
+2,749
New +$422K 0.17% 118

Other funds holding ABBV

Farther Finance Advisors's ABBV Position: Q2 2026 in Review

Farther Finance Advisors increased its AbbVie (ABBV) stake by 11% in Q2 2026, buying an estimated $2.62M and bringing the position to 119,959 shares worth $30.2M. The position accounts for 0.24% of the portfolio, ranked #80.

Farther Finance Advisors first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Farther Finance Advisors held 119,959 shares of AbbVie worth $30.2M as of Q2 2026.
  • Farther Finance Advisors bought 12,189 AbbVie shares in Q2 2026, an estimated $2.62M.
  • AbbVie made up 0.24% of Farther Finance Advisors's portfolio in Q2 2026, its #80 holding.
  • Farther Finance Advisors first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.